Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2Zhihao Liu, Luoting Yu, Xi Hu et al.|Journal of Medicinal Chemistry|2021Cited by 116
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defectQian Lei, Luoting Yu, Lu Xiong et al.|Cell Death and Disease|2018Cited by 65
Discovery of Imidazo[2,1-<i>b</i>]thiazole HCV NS4B Inhibitors Exhibiting Synergistic Effect with Other Direct-Acting Antiviral AgentsNingyu Wang, Luoting Yu, Ying Xu et al.|Journal of Medicinal Chemistry|2015Cited by 43
Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasisTiantao Gao, Luoting Yu, Xi Hu et al.|Cancer Letters|2018Cited by 43
Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agentsKai Ran, Luoting Yu, Chao Gao et al.|Bioorganic & Medicinal Chemistry Letters|2016Cited by 39